Litcius/Paper detail

Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3”

Kebede H. Begna, Xiuping Xu, Naseema Gangat, Hassan B. Alkhateeb, Mrinal M. Patnaik, Aref Al‐Kali, Michelle A. Elliott, William J. Hogan, Mark R. Litzow, C. C. Hook, Alexandra P. Wolanskyj, Abhishek A. Mangaonkar, Rong He, Animesh Pardanani, Mithun Vinod Shah, Rhett P. Ketterling, Ayalew Tefferi

2022Blood Cancer Journal20 citationsDOIOpen Access PDF

Topics & Concepts

Myeloid leukemiaTerm (time)MedicineLeukemiaCore binding factorOutcome (game theory)Internal medicineCore (optical fiber)OncologyHematologyMyeloidImmunologyBioinformaticsBiologyComputer scienceGeneticsMathematicsQuantum mechanicsTranscription factorMathematical economicsTelecommunicationsPhysicsGeneAcute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processesChronic Myeloid Leukemia Treatments
Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3” | Litcius